IMGN logo

ImmunoGen (IMGN) Return On Equity

Annual ROE

-92.61%
-25.50%-38.00%

December 31, 2022


Summary


Performance

IMGN ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIMGNprofitabilitymetrics:

Quarterly ROE

-24.37%
+51.70%+67.96%

September 30, 2023


Summary


Performance

IMGN Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIMGNprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

IMGN ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-38.0%+72.4%
3 y3 years-167.7%-112.7%
5 y5 years-117.3%+96.4%

IMGN ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year+38.0%at lowat high+386.1%
5 y5-year-167.7%+612.5%-112.7%+3934.3%
alltimeall time-117.3%+1561.6%-103.1%+6935.0%

ImmunoGen ROE History

DateAnnualQuarterly
Sep 2023
-
-24.37%(-68.0%)
Jun 2023
-
-76.07%(-35.8%)
Mar 2023
-
-118.47%(+29.2%)
Dec 2022
-92.61%(+38.0%)
-91.69%(+3.7%)
Sep 2022
-
-88.43%(+13.1%)
Jun 2022
-
-78.19%(+5.3%)
Mar 2022
-
-74.22%(-30.2%)
Dec 2021
-67.11%(-89.8%)
-106.37%(-13.9%)
Sep 2021
-
-123.52%(-18.2%)
Jun 2021
-
-150.96%(-31.4%)
Mar 2021
-
-219.91%(-77.6%)
Dec 2020
-659.86%(-582.4%)
-983.15%(-611.5%)
Sep 2020
-
192.22%(+30.5%)
Jun 2020
-
147.29%(-3.4%)
Mar 2020
-
152.53%(-5.5%)
Dec 2019
136.80%(-108.9%)
161.37%(-54.2%)
Sep 2019
-
352.56%(-120.6%)
Jun 2019
-
-1714.42%(+63.8%)
Mar 2019
-
-1046.38%(+15.1%)
Dec 2018
-1538.85%(-386.8%)
-909.28%(+32.8%)
Sep 2018
-
-684.79%(-187.1%)
Jun 2018
-
786.45%(+467.9%)
Mar 2018
-
138.49%(+69.5%)
Dec 2017
536.53%(+939.6%)
81.72%(+48.6%)
Sep 2017
-
55.01%(+19.7%)
Jun 2017
-
45.94%(-47.2%)
Mar 2017
-
87.01%(-63.3%)
Dec 2016
51.61%(-70.7%)
-
Sep 2016
-
237.27%(-47.4%)
Jun 2016
175.95%(-260.5%)
450.71%(-133.8%)
Mar 2016
-
-1332.22%(+274.1%)
Dec 2015
-
-356.11%(+139.5%)
Sep 2015
-
-148.66%(+50.2%)
Jun 2015
-109.63%(+51.7%)
-98.95%(+28.9%)
Mar 2015
-
-76.76%(-6.9%)
Dec 2014
-
-82.48%(-3.5%)
Sep 2014
-
-85.48%(+30.5%)
Jun 2014
-72.25%(+2.1%)
-65.48%(+19.4%)
Mar 2014
-
-54.86%(+131.5%)
Dec 2013
-
-23.70%(-45.7%)
Sep 2013
-
-43.68%(-23.4%)
Jun 2013
-70.78%(+8.1%)
-57.06%(-4.0%)
Mar 2013
-
-59.43%(-22.2%)
Dec 2012
-
-76.39%(+12.4%)
Sep 2012
-
-67.98%(+4.6%)
Jun 2012
-65.50%(+36.0%)
-65.01%(+5.6%)
Mar 2012
-
-61.54%(+1.4%)
Dec 2011
-
-60.71%(-6.9%)
Sep 2011
-
-65.23%(+6.5%)
Jun 2011
-48.16%(-20.1%)
-61.27%(-18.0%)
Mar 2011
-
-74.73%(+0.2%)
Dec 2010
-
-74.57%(-4.0%)
Sep 2010
-
-77.64%(-6.2%)
Jun 2010
-60.28%(+15.3%)
-82.78%(-16.6%)
Mar 2010
-
-99.24%(+20.9%)
Dec 2009
-
-82.06%(+17.4%)
Sep 2009
-
-69.89%(+8.9%)
Jun 2009
-52.29%(-7.2%)
-64.20%(-13.2%)
Mar 2009
-
-73.97%(-14.5%)
Dec 2008
-
-86.56%(+9.4%)
Sep 2008
-
-79.09%(+31.6%)
Jun 2008
-56.32%(+93.9%)
-60.11%(+33.2%)
Mar 2008
-
-45.12%(+57.9%)
Dec 2007
-
-28.57%(+28.8%)
Sep 2007
-
-22.19%(-24.2%)
Jun 2007
-29.04%(+29.6%)
-29.26%(-4.5%)
Mar 2007
-
-30.63%(+17.4%)
Dec 2006
-
-26.08%(+2.5%)
Sep 2006
-
-25.44%(+14.3%)
DateAnnualQuarterly
Jun 2006
-22.41%(+88.3%)
-22.25%(+33.6%)
Mar 2006
-
-16.65%(-0.7%)
Dec 2005
-
-16.76%(+13.5%)
Sep 2005
-
-14.77%(+24.2%)
Jun 2005
-11.90%(+101.0%)
-11.89%(+41.0%)
Mar 2005
-
-8.43%(+57.0%)
Dec 2004
-
-5.37%(+22.0%)
Sep 2004
-
-4.40%(-26.8%)
Jun 2004
-5.92%(-64.9%)
-6.01%(-53.6%)
Mar 2004
-
-12.95%(-19.4%)
Dec 2003
-
-16.06%(-14.2%)
Sep 2003
-
-18.72%(+11.2%)
Jun 2003
-16.87%(+59.5%)
-16.83%(+20.6%)
Mar 2003
-
-13.96%(-6.7%)
Dec 2002
-
-14.96%(+27.0%)
Sep 2002
-
-11.78%(+13.5%)
Jun 2002
-10.58%(-45.4%)
-10.38%(+11.0%)
Mar 2002
-
-9.35%(+64.0%)
Dec 2001
-
-5.70%(-22.6%)
Sep 2001
-
-7.36%(-52.7%)
Jun 2001
-19.38%(+742.6%)
-15.57%(-0.1%)
Mar 2001
-
-15.58%(-43.2%)
Dec 2000
-
-27.43%(-53.6%)
Sep 2000
-
-59.07%(+3437.1%)
Jun 2000
-2.30%(-97.3%)
-1.67%(-87.0%)
Mar 2000
-
-12.87%(-205.5%)
Dec 1999
-
12.20%(-190.3%)
Sep 1999
-
-13.51%(-84.5%)
Jun 1999
-85.42%(-50.5%)
-87.23%(-35.5%)
Mar 1999
-
-135.19%(-8.2%)
Dec 1998
-
-147.30%(-1.9%)
Sep 1998
-
-150.21%(-6.3%)
Jun 1998
-172.73%(-30.9%)
-160.34%(+13.2%)
Mar 1998
-
-141.70%(-12.1%)
Dec 1997
-
-161.16%(-21.9%)
Sep 1997
-
-206.31%(-13.8%)
Jun 1997
-250.00%(-3.0%)
-239.36%(-33.1%)
Mar 1997
-
-357.56%(-5.4%)
Dec 1996
-
-377.98%(+10.9%)
Sep 1996
-
-340.81%(+26.8%)
Jun 1996
-257.81%(+159.8%)
-268.73%(+47.9%)
Mar 1996
-
-181.71%(+36.8%)
Dec 1995
-
-132.86%(+30.9%)
Sep 1995
-
-101.47%(+17.4%)
Jun 1995
-99.25%(+47.6%)
-86.45%(+3.4%)
Mar 1995
-
-83.64%(+4.3%)
Dec 1994
-
-80.20%(+2.6%)
Sep 1994
-
-78.16%(+13.1%)
Jun 1994
-67.23%(+80.0%)
-69.11%(+16.0%)
Mar 1994
-
-59.57%(+15.1%)
Dec 1993
-
-51.76%(+19.6%)
Sep 1993
-
-43.26%(+16.8%)
Jun 1993
-37.35%(+23.4%)
-37.04%(+15.3%)
Mar 1993
-
-32.13%(-0.5%)
Dec 1992
-
-32.29%(+8.9%)
Sep 1992
-
-29.66%(-5.3%)
Jun 1992
-30.27%(-6.8%)
-31.31%(-13.1%)
Mar 1992
-
-36.01%(+15.2%)
Dec 1991
-
-31.26%(-27.9%)
Sep 1991
-
-43.33%(+15.3%)
Jun 1991
-32.47%(-52.3%)
-37.57%(-19.7%)
Mar 1991
-
-46.77%(-62.6%)
Dec 1990
-
-125.00%(-80.1%)
Sep 1990
-
-627.27%(+711.2%)
Jun 1990
-68.03%(-10.1%)
-77.33%(-4.7%)
Mar 1990
-
-81.11%(-24.4%)
Dec 1989
-
-107.32%(+11.9%)
Sep 1989
-
-95.93%(+26.7%)
Jun 1989
-75.71%
-75.71%

FAQ

  • What is ImmunoGen annual return on equity?
  • What is the all time high annual ROE for ImmunoGen?
  • What is ImmunoGen annual ROE year-on-year change?
  • What is ImmunoGen quarterly return on equity?
  • What is the all time high quarterly ROE for ImmunoGen?
  • What is ImmunoGen quarterly ROE year-on-year change?

What is ImmunoGen annual return on equity?

The current annual ROE of IMGN is -92.61%

What is the all time high annual ROE for ImmunoGen?

ImmunoGen all-time high annual return on equity is 536.53%

What is ImmunoGen annual ROE year-on-year change?

Over the past year, IMGN annual return on equity has changed by -25.50% (-38.00%)

What is ImmunoGen quarterly return on equity?

The current quarterly ROE of IMGN is -24.37%

What is the all time high quarterly ROE for ImmunoGen?

ImmunoGen all-time high quarterly return on equity is 786.45%

What is ImmunoGen quarterly ROE year-on-year change?

Over the past year, IMGN quarterly return on equity has changed by +64.06% (+72.44%)